CY-208,243
Appearance
(Redirected from C19H18N2)
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C19H18N2 |
Molar mass | 274.367 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
CY-208,243 is a drug which acts as a dopamine agonist selective for the D1 subtype. Unlike most D1-selective agonists, it shows efficacy in animal models of Parkinson's disease.[1][2][3][4][5]
References
[edit]- ^ Gagnon C, Gomez-Mancilla B, Markstein R, Bédard PJ, Di Paolo T (July 1995). "Effect of adding the D-1 agonist CY 208-243 to chronic bromocriptine treatment of MPTP-monkeys: regional changes of brain dopamine receptors". Progress in Neuro-psychopharmacology & Biological Psychiatry. 19 (4): 667–76. doi:10.1016/0278-5846(95)00110-h. PMID 8588064. S2CID 26670068.
- ^ Beninger RJ, Rolfe NG (December 1995). "Dopamine D1-like receptor agonists impair responding for conditioned reward in rats". Behavioural Pharmacology. 6 (8): 785–793. doi:10.1097/00008877-199512000-00003. PMID 11224381. S2CID 23656469.
- ^ Luquin MR, Guillén J, Legarda I, Cruz Rodriguez M, Del Rio L, Dominguez J, Martínez-Lage JM (1996). "Pulsatile administration of D1 but not D2 dopamine agonists induces behavioral tolerance in MPTP-treated monkeys". Advances in Neurology. 69: 239–44. PMID 8615134.
- ^ D'Aquila PS, Panin F, Cossu M, Peana AT, Serra G (January 2003). "Dopamine D1 receptor agonists induce penile erections in rats". European Journal of Pharmacology. 460 (1): 71–4. doi:10.1016/S0014-2999(02)02881-9. PMID 12535862.
- ^ Salamone JD, Carlson BB, Rios C, Lentini E, Correa M, Wisniecki A, Betz A (January 2005). "Dopamine agonists suppress cholinomimetic-induced tremulous jaw movements in an animal model of Parkinsonism: tremorolytic effects of pergolide, ropinirole and CY 208-243". Behavioural Brain Research. 156 (2): 173–9. doi:10.1016/j.bbr.2004.05.019. PMID 15582103. S2CID 10255277.